MedTech Terms
    The authoritative reference
    All terms
    Investment & FinanceStartup Lifecycle

    Burn Rate

    Rate at which a company spends cash, typically expressed monthly.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Burn rate is the speed at which a company consumes its cash reserves. Gross burn = total monthly operating expenses; net burn = gross burn minus revenue. Burn usually rises sharply during pivotal trials and commercial launch. Investors compare burn to milestone progress to judge capital efficiency. Tracking burn by program helps leaders decide which projects to pause if funding is tight.
    What the regulation says
    While burn rate is primarily a financial metric, regulatory bodies like the FDA or those overseeing EU MDR do not directly regulate a company's burn rate. However, financial stability, indirectly reflected by a sustainable burn rate, is crucial for maintaining a robust Quality Management System (QMS) and ensuring continuous compliance with regulations such as 21 CFR 820, ISO 13485, or the EU MDR. Adequate funding prevents shortcuts that could compromise device safety and effectiveness.

    What this means in practice

    Pre-revenue MedTech companies have only gross burn. As commercial sales begin, net burn becomes the meaningful metric.

    Examples

    • A startup MedTech company uses its gross burn rate to project how long its seed funding will last before needing to secure additional investment for ISO 13485 certification and initial regulatory submissions.
    • A company developing a novel diagnostic device projects its net burn rate to ensure it can cover ongoing operational costs, clinical trial expenses, and eventual FDA 510(k) submission fees.
    • During a post-market surveillance phase, a company analyzes its burn rate to confirm it has sufficient funds for handling potential adverse event reporting as required by EU MDR Annex III and continuous improvement activities.
    Common pitfalls
    • •Confusing burn rate with profitability; a company can have a high burn rate while still being profitable if revenue significantly outpaces expenses.
    • •Underestimating the financial resources required for clinical trials, regulatory submissions, and post-market surveillance activities.
    • •Failing to account for unexpected delays in regulatory approvals or market adoption, which can significantly extend the period of cash consumption.
    • •Overlooking the impact of supply chain disruptions or quality issues on cash flow, as these can necessitate unplanned expenditures.

    Frequently asked questions

    A healthy burn rate ensures a company can afford proper quality control, regulatory expertise, and necessary post-market activities, all vital for compliance. Insufficient funds may lead to a reduction in crucial quality or regulatory personnel and processes, potentially causing non-compliance.

    Related terms

    Grouped by theme
    Cited by

    Where this term appears across MedTech Terms.

    Ecosystems (1)

    Latest in MedTech

    Sources

    4 sources

    Sources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

    Tier 2Regulator guidance and consensus· 1Tier 4Trade press and expert commentary· 3
    Link health: 4 verified· last checked 2026-06-20· added official documents checked 2026-11-01
    SVB·1PitchBook·1NVCA·1U.S. Securities and Exchange Commission·1
    1. 1
      Silicon Valley Bank - Healthcare Reports
      Tier 4 Verified
      SVBsvb.com
    2. 2
      PitchBook - MedTech Coverage
      Tier 4 Verified
      PitchBookpitchbook.com
    3. 3
      NVCA Model Documents
      Tier 4 Verified
      NVCAnvca.org
    4. 4
      SEC capital-raising glossary: burn rate
      Tier 2 Verified
      U.S. Securities and Exchange Commissionsec.gov

    Inline markers like [1] jump to the matching reference above.